Robert Gardella
Psychiatry · Staunton, VANPI 1770540932
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $178,508 of the $200,747 with a category attached, or 88.9%. 15 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 54.9% of the total. Among psychiatry clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 314 payments — averaging $639.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$110K
- Alkermes, Inc.$70K
- Johnson & Johnson$10K
- Sunovion Pharmaceuticals Inc.$8K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$671
- E.r. Squibb & Sons, L.L.C.$569
- plus $966 from 9 others
What the payments were for
- Speaking & faculty fees$178,50889%
- Travel & lodging$13,0567%
- Food & beverage$9,1135%
- Education$700%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 105 | $110,123 |
| Alkermes, Inc. | 104 | $70,418 |
| Johnson & Johnson | 38 | $9,979 |
| Sunovion Pharmaceuticals Inc. | 14 | $8,021 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $671 |
| E.r. Squibb & Sons, L.L.C. | 17 | $569 |
| Neurocrine Biosciences, Inc. | 3 | $255 |
| Bioxcel Therapeutics, Inc. | 5 | $241 |
| Lundbeck LLC | 6 | $141 |
| Otsuka America Pharmaceutical, Inc. | 5 | $104 |
| Jazz Pharmaceuticals Inc. | 1 | $72 |
| AbbVie | 2 | $61 |
| Janssen Scientific Affairs, LLC | 1 | $39 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $35 |
| Indivior Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$274,444
- UZEDY$107,224
- ARISTADA INITIO$68,611
- LATUDA$7,879
- SPRAVATO$6,156
- INVEGA SUSTENNA$3,106
- INVEGA TRINZA$3,106
- Austedo XR$1,225
- CAPLYTA$365
- INGREZZA$243
- COBENFY$119
How this compares
$200,747 in reported general payments places this provider in the 95th percentile of 884 psychiatry providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Risperidone | 11 | $139 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Staunton
- Timothy KaneStaunton$162K
- Niku SinghFalls Church$2.5M
- David ScheidererRoanoke$2.4M
- Kent McDanielGlen Allen$2.1M
- Jasdeep MiglaniManassas$958K
- David SpiegelNorfolk$565K
- William YetterVirginia Beach$312K
- Anita ClaytonCharlottesville$260K
- Ralph McKenzieRoanoke$161K
- Ifeanyi OleleFairfax$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.